We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adults with hypothyroidism diagnosed with myxedema coma ...

SAN DIEGO — Myxedema coma, a rare but potentially fatal form of decompensated hypothyroidism, can be identified according to key clinical signs and successfully treated in most patients with 500 µg of ...

Please provide your email address to receive an email when new articles are posted on . CORONADO, Calif. — Myxedema coma can be safely and effectively treated with IV levothyroxine, according to ...

SCHAUMBURG, Ill. — APP Pharmaceuticals has received regulatory approval for the treatment of a complication related to hypothyroidism. APP said that its levothyroxine sodium for injection will be ...

Shares of the company were trading 0.19 per cent up at ₹483.20 apiece on the BSE.. Photo: Mint Zydus Lifesciences on Tuesday said it has received approval from the US health regulator to market a ...

Zydus Lifesciences has received approval from the United States Food and Drug Administration (USFDA) to market Levothyroxine Sodium injection, used to treat thyroid hormone deficiency. The company's ...

Zydus Lifesciences on Tuesday said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma. The company has received the final approval ...

Levothyroxine Sodium Injection is indicated for the treatment of myxedema coma. Zydus said the drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara (India ...